Skip to content
OpenCapital
Get started

Processa Pharmaceuticals, Inc. PCSA Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

EPS-$0.74Beat by $0.18
EPS estimate-$0.92

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$1.00

Versus estimates

Diluted EPS

Q1 2026-$1.29Miss by $0.29Q4 2025-$18.50Miss by $17.00Q3 2025-$1.75Beat by $0.25Q2 2025-$0.25Miss by $0.02Q1 2025-$0.30Beat by $0.47
Q4 2024-$0.74Beat by $0.18

Ask the moment Processa Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Processa Pharmaceuticals, Inc. report Q4 2024 earnings?
Processa Pharmaceuticals, Inc. (PCSA) reported Q4 2024 earnings on March 20, 2025 before market open.
What were Processa Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?
Processa Pharmaceuticals, Inc. reported eps of $-0.74 for Q4 2024.
Did Processa Pharmaceuticals, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.92 by $0.18.
Where can I find Processa Pharmaceuticals, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641172-25-000070) directly on SEC EDGAR. The filing index links above go to sec.gov.